The Cost-Effectiveness Of HAART Underestimated
Bohdan Nosyk and Julio Montaner of the British Columbia Centre for Excellence in HIV/AIDS in Vancouver, Canada argue in an Essay published in this week's PLoS Medicine that the cost-effectiveness of HAART roll out has been significantly underestimated, because economic analyses have not yet taken into account the beneficial impact of HAART on prevention of HIV transmission...
Rate this article



del.icio.us
Digg
Comments (0 posted):
Post your comment